Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
Objective: Covered stents are an important tool in managing femoropopliteal peripheral arterial disease. However, their performance is impaired by edge neointimal hyperplasia and restenosis. We examined the effectiveness of prophylactic deployment of paclitaxel-eluting stents to prevent edge resteno...
Enregistré dans:
Auteurs principaux: | Rory Marples, MBBS, Matthew Binks, MBBS, Roberto Spina, MBBS, MSc, MPH, FRACP, Melissa Wright, MD, Ravi Huilgol, MBBS, FRACS |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/151040d0d3a44a95b7e70b56e61a2849 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
par: Ikushima I, et autres
Publié: (2011) -
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
par: Litsky J, et autres
Publié: (2014) -
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
par: Xinlin Zhang, et autres
Publié: (2014) -
Everolimus-eluting coronary stents
par: Alejandro Saez, et autres
Publié: (2010) -
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
par: Kyriacos Papadopoulos, et autres
Publié: (2021)